GenomeWeb reported yesterday that Sigma-Aldrich was going to co-market the Genius sequencer. There was no launch date mentioned.
-
-
NanoString Developing Novel Sequencing Chemistry Based on Optical Barcoding
At the JP Morgan Healthcare Conference, NanoString Technologies CEO Brad Gray said that the firm has been developing a novel single-molecule hybridization-based sequencing chemistry that leverages the company's optical barcoding technology.
Gray declined to provide details on the chemistry, which he dubbed Hyb&Seq, but said that it would be single-molecule, based on hybridization, and would not require amplification, the use of enzymes, or even library prep.
[Link to Genomeweb article]
[Link to NanoString Presentation]Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment